Adhikary, Sulekha <br/><br/>
FGF-2 targets sclerostin in bone and myostatin in skeletal muscle to mitigate the deleterious effects of glucocorticoid on musculoskeletal degradation.  [electronic resource] 

 -  Life sciences  Jul 2019 
 - 261-276 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0631 
<br/><br/><label>Standard No.: </label>10.1016/j.lfs.2019.05.022  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Animals<br/>Bone and Bones--drug effects<br/>Cell Differentiation<br/>Cells, Cultured<br/>Dexamethasone--toxicity<br/>Fibroblast Growth Factor 2--pharmacology<br/>Glucocorticoids--toxicity<br/>Glycoproteins--antagonists & inhibitors<br/>Intercellular Signaling Peptides and Proteins<br/>Mice<br/>Muscle, Skeletal--drug effects<br/>Musculoskeletal Diseases--chemically induced<br/>Myostatin--antagonists & inhibitors<br/>Osteoblasts--cytology<br/>Osteogenesis--drug effects